Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.170
-0.070 (-5.65%)
Feb 20, 2026, 4:00 PM EST - Market closed
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $2.1 million as of February 23, 2026. Its market cap has decreased by -67.85% in one year.
Market Cap
2.10M
Enterprise Value
-1.71M
1-Year Change
-67.85%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.16M to $2.10M, a decrease of -91.97%. That is a compound annual growth rate of -42.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 2.10M | -22.64% |
| Dec 31, 2025 | 2.71M | -55.12% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.12% |
| Dec 30, 2022 | 7.82M | -59.15% |
| Dec 27, 2021 | 19.13M | -26.88% |
| Aug 16, 2021 | 26.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adial Pharmaceuticals | 2.72M |
| Artelo Biosciences | 2.66M |
| SciSparc | 2.66M |
| XORTX Therapeutics | 2.59M |
| Lyra Therapeutics | 2.57M |
| Scinai Immunotherapeutics | 2.50M |
| Bone Biologics | 2.15M |
| CNS Pharmaceuticals | 1.99M |